Mechanism of osteogenic induction by FK506 via BMP/Smad pathways

Fumitaka Kugimiya, Fumiko Yano, Shinsuke Ohba, Kazuyo Igawa, Kozo Nakamura, Hiroshi Kawaguchi, Ung Il Chung

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

FK506 is an immunosuppressant that exerts effects by binding to FK506-binding protein 12 (FKBP12). Recently, FK506 has also been reported to promote osteogenic differentiation when administered locally or in vitro in combination with bone morphogenetic proteins (BMPs), although the underlying mechanism remains unclarified. The present study initially showed that FK506 alone at a higher concentration (1 μM) induced osteogenic differentiation of mesenchymal cell lines, which was suppressed by adenoviral introduction of Smad6. FK506 rapidly activates the BMP-dependent Smads in the absence of BMPs, and the activation was blocked by Smad6. Overexpression of FKBP12, which was reported to block the ligand-independent activation of BMP type I receptor A (BMPRIA), suppressed Smad signaling induced by FK506, but not that induced by BMP2. BMPRIA and FKBP12 bound to each other, and this binding was suppressed by FK506. These data suggest that FK506 promotes osteogenic differentiation by activating BMP receptors through interacting with FKBP12.

Original languageEnglish
Pages (from-to)872-879
Number of pages8
JournalBiochemical and Biophysical Research Communications
Volume338
Issue number2
DOIs
Publication statusPublished - Dec 16 2005
Externally publishedYes

Fingerprint

Bone Morphogenetic Proteins
Tacrolimus
Tacrolimus Binding Proteins
Type I Bone Morphogenetic Protein Receptors
Chemical activation
Bone Morphogenetic Protein Receptors
Immunosuppressive Agents
Cells
Ligands
Cell Line

Keywords

  • BMP
  • FK506
  • FKBP12
  • Osteoblast
  • Osteogenic differentiation
  • Smad

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Mechanism of osteogenic induction by FK506 via BMP/Smad pathways. / Kugimiya, Fumitaka; Yano, Fumiko; Ohba, Shinsuke; Igawa, Kazuyo; Nakamura, Kozo; Kawaguchi, Hiroshi; Chung, Ung Il.

In: Biochemical and Biophysical Research Communications, Vol. 338, No. 2, 16.12.2005, p. 872-879.

Research output: Contribution to journalArticle

Kugimiya, Fumitaka ; Yano, Fumiko ; Ohba, Shinsuke ; Igawa, Kazuyo ; Nakamura, Kozo ; Kawaguchi, Hiroshi ; Chung, Ung Il. / Mechanism of osteogenic induction by FK506 via BMP/Smad pathways. In: Biochemical and Biophysical Research Communications. 2005 ; Vol. 338, No. 2. pp. 872-879.
@article{49d662f760b5457a8e97ceaf1fa56b83,
title = "Mechanism of osteogenic induction by FK506 via BMP/Smad pathways",
abstract = "FK506 is an immunosuppressant that exerts effects by binding to FK506-binding protein 12 (FKBP12). Recently, FK506 has also been reported to promote osteogenic differentiation when administered locally or in vitro in combination with bone morphogenetic proteins (BMPs), although the underlying mechanism remains unclarified. The present study initially showed that FK506 alone at a higher concentration (1 μM) induced osteogenic differentiation of mesenchymal cell lines, which was suppressed by adenoviral introduction of Smad6. FK506 rapidly activates the BMP-dependent Smads in the absence of BMPs, and the activation was blocked by Smad6. Overexpression of FKBP12, which was reported to block the ligand-independent activation of BMP type I receptor A (BMPRIA), suppressed Smad signaling induced by FK506, but not that induced by BMP2. BMPRIA and FKBP12 bound to each other, and this binding was suppressed by FK506. These data suggest that FK506 promotes osteogenic differentiation by activating BMP receptors through interacting with FKBP12.",
keywords = "BMP, FK506, FKBP12, Osteoblast, Osteogenic differentiation, Smad",
author = "Fumitaka Kugimiya and Fumiko Yano and Shinsuke Ohba and Kazuyo Igawa and Kozo Nakamura and Hiroshi Kawaguchi and Chung, {Ung Il}",
year = "2005",
month = "12",
day = "16",
doi = "10.1016/j.bbrc.2005.10.024",
language = "English",
volume = "338",
pages = "872--879",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Mechanism of osteogenic induction by FK506 via BMP/Smad pathways

AU - Kugimiya, Fumitaka

AU - Yano, Fumiko

AU - Ohba, Shinsuke

AU - Igawa, Kazuyo

AU - Nakamura, Kozo

AU - Kawaguchi, Hiroshi

AU - Chung, Ung Il

PY - 2005/12/16

Y1 - 2005/12/16

N2 - FK506 is an immunosuppressant that exerts effects by binding to FK506-binding protein 12 (FKBP12). Recently, FK506 has also been reported to promote osteogenic differentiation when administered locally or in vitro in combination with bone morphogenetic proteins (BMPs), although the underlying mechanism remains unclarified. The present study initially showed that FK506 alone at a higher concentration (1 μM) induced osteogenic differentiation of mesenchymal cell lines, which was suppressed by adenoviral introduction of Smad6. FK506 rapidly activates the BMP-dependent Smads in the absence of BMPs, and the activation was blocked by Smad6. Overexpression of FKBP12, which was reported to block the ligand-independent activation of BMP type I receptor A (BMPRIA), suppressed Smad signaling induced by FK506, but not that induced by BMP2. BMPRIA and FKBP12 bound to each other, and this binding was suppressed by FK506. These data suggest that FK506 promotes osteogenic differentiation by activating BMP receptors through interacting with FKBP12.

AB - FK506 is an immunosuppressant that exerts effects by binding to FK506-binding protein 12 (FKBP12). Recently, FK506 has also been reported to promote osteogenic differentiation when administered locally or in vitro in combination with bone morphogenetic proteins (BMPs), although the underlying mechanism remains unclarified. The present study initially showed that FK506 alone at a higher concentration (1 μM) induced osteogenic differentiation of mesenchymal cell lines, which was suppressed by adenoviral introduction of Smad6. FK506 rapidly activates the BMP-dependent Smads in the absence of BMPs, and the activation was blocked by Smad6. Overexpression of FKBP12, which was reported to block the ligand-independent activation of BMP type I receptor A (BMPRIA), suppressed Smad signaling induced by FK506, but not that induced by BMP2. BMPRIA and FKBP12 bound to each other, and this binding was suppressed by FK506. These data suggest that FK506 promotes osteogenic differentiation by activating BMP receptors through interacting with FKBP12.

KW - BMP

KW - FK506

KW - FKBP12

KW - Osteoblast

KW - Osteogenic differentiation

KW - Smad

UR - http://www.scopus.com/inward/record.url?scp=27744588940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27744588940&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2005.10.024

DO - 10.1016/j.bbrc.2005.10.024

M3 - Article

VL - 338

SP - 872

EP - 879

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 2

ER -